ReviewClinicoEconomics and outcomes research : CEOR2017

Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?

Elizabeth M Adkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.